The Claim

Pancreatic cystic lesions, including intraductal papillary mucinous neoplasms (IPMNs) and pancreatic neuroendocrine tumors (pNETs), may impair endocrine function and contribute to glucose dysregulation even in individuals who do not have overt diabetes or exocrine pancreatic insufficiency.

Source: Normal glycosylated hemoglobin masking glucose dysregulation in a patient with pancreatic and hematologic disease

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
24score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Some types of cysts or tumors in the pancreas might mess with blood sugar control, even if a person doesn’t have diabetes or obvious pancreas problems.

See the scientific wording

Pancreatic cystic lesions such as intraductal papillary mucinous neoplasms (IPMNs) or pancreatic neuroendocrine tumors (pNETs) may impair endocrine function and contribute to glucose dysregulation even in the absence of overt diabetes or pancreatic insufficiency.

What the research says

1 study

  1. Study: Normal glycosylated hemoglobin masking glucose dysregulation in a patient with pancreatic and hematologic disease

    The study looked at a woman with pancreatic growths and found her blood sugar was unstable even though a common diabetes test showed normal results. This supports the idea that these growths can mess up blood sugar control before diabetes is diagnosed.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.